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In this study, we are pioneering new nanotechnology for the encapsulation of
anticancer drugs (doxorubicin (DOX) and/or docetaxel (DOCE)), whatever their
solubility and water affinity. The purpose of this study is to highlight the potential
of this recently patented technology, by carrying out a thorough physicochemical
characterisation of these multiscaled nanocarriers, followed by the study of an
encapsulation and release model of hydrophilic anticancer drug. The formulation
process is based on a low-energy nano-emulsification method and allows the
generation of a structure composed of oil-based nanocarriers loaded with reverse
micelles. Thanks to this, hydrophilic contents can be solubilised in the oily core of
this kind of nano-emulsion along with lipophilic content. The results emphasise
some original structure particularities due to the multistep formulation process, and
the diffusion-based behaviour revealed for the DOX release profile that is shown to
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